The expression of GFAP and these oligodendrocyte progenitor surface markers suggests that along the oligodendrocyte lineage differentiation hierarchy, A2B5+/PDGFRα+ glioma cells were compromised in differentiation downstream of A2B5/O4, but upstream of the O1 stage. This evidence concerns the gene GFAP and central nervous system cancer.